Result of General Meeting

Provided By GlobeNewswire

Last update: Jun 11, 2025

June 11, 2025

Biodexa Pharmaceuticals PLC

Result of General Meeting

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces, announces that at its General Meeting held earlier today, all four resolutions put to the Company’s shareholders were duly passed.